Back
Brainstorm Cell Therapeutics Vs. Oragenics Industry Stock Comparison
Buy
54
BCLI
Brainstorm Cell Therapeutics
Last Price:
0.57
Seasonality Move:
13.93%
Buy
72
OGEN
Oragenics
Last Price:
2.17
Seasonality Move:
17.1%
Buy
54
Brainstorm Cell Therapeutics (BCLI)
is a Buy
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $0.57. The Score for BCLI is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- BCLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Oragenics (OGEN)
is a Buy
Is Oragenics a Buy, Sell or Hold?
- The current Oragenics [OGEN] share price is $2.51. The Score for OGEN is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- OGEN is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $0.57
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCLI is experiencing slight selling pressure.
OGEN Stock Price Chart
BCLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 56.63 | Buy |
| Chaikin Money Flow: | -282986 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.42 - 0.56) | Buy |
| Bollinger Bands (100): | (0.31 - 0.55) | Buy |
OGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 65.17 | Buy |
| Chaikin Money Flow: | 304289 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.87 - 2.09) | Buy |
| Bollinger Bands (100): | (0.88 - 4.3) | Sell |
BCLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.54 | Buy |
| 20-day SMA: | 0.48 | Buy |
| 50-day SMA: | 0.52 | Buy |
| 200-day SMA: | 0.52 | Buy |
| 8-day EMA: | 0.54 | Buy |
| 20-day EMA: | 0.51 | Buy |
| 50-day EMA: | 0.49 | Buy |
| 200-day EMA: | 0.73 | Sell |
OGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.17 | Buy |
| 20-day SMA: | 1.58 | Buy |
| 50-day SMA: | 1.41 | Buy |
| 200-day SMA: | 3.1 | Sell |
| 8-day EMA: | 2.29 | Buy |
| 20-day EMA: | 1.82 | Buy |
| 50-day EMA: | 1.76 | Buy |
| 200-day EMA: | 3.22 | Sell |
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.05 per share.
Oragenics Earnings Growth & OGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Brainstorm Cell Therapeutics Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oragenics Technical Analysis
| May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||